Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
OFX
Consumer Small Caps Stocks
OFX (ASX:OFX): After backflipping on its growth promises and spending months in the doldrums, maybe there’s light at the end of the tunnel?
OFX (ASX:OFX) shares shed more than two thirds of their value from October 2024 to June 2025 after a weak trading update. But its most recent trading update has shown there might be hope for shareholders.OFX Share price chart, log scale (Source: Google) Introduction to OFX OFX was founded in 1998 by Matthew Gilmour and Gary…
September 10, 20250Comments
Artrya
Biotech Stocks Healthcare Stocks
Artrya (ASX:AYA): With FDA 510(k) approval and $75m in fresh capital, its all systems go!
4 years after listing and over 7 years after its founding, Artrya (ASX:AYA) achieved the aspiration of most ASX medtechs, in obtaining FDA approval. Its Salix suite of products aims to improve the detection and treatment of Coronary Artery Disease (CAD), which is a major cause of heart attacks.Entering the US was always this company's…
September 10, 20250Comments
Actinogen Medical
Healthcare Stocks Life Sciences Penny Stocks Small Caps Stocks
Actinogen Medical (ASX:ACW): Will history repeat itself? Can it bounce back from a troublesome Phase 2 trial?
Actinogen Medical (ASX:ACW) is the poster child for how volatile biotech stocks can be. the last time we wrote about this company was in August last year when shares more than halved after results of a Phase II trial that investors perceived to be a flop. But the company has soldiered on and has a…
September 9, 20250Comments
Weebit Nano
Semiconductor stocks Small Caps Stocks Tech Stocks Technology
Here’s what investors need to know about ReRAM and how ASX chip stocks can make big bucks from it!
Our longer term readers would know we are big fans of Weebit Nano (ASX:WBT), a company commercialising its own version of a technology known as ReRAM (Resistive Random-Access Memory). We've spoken a lot about Weebit and certain other chip stocks embracing it (which we'll get into shortly), but we've never written an article focused on…
September 8, 20250Comments
Imricor Medical Systems
Healthcare Stocks Small Caps Stocks Tech Stocks Technology
Imricor Medical Systems (ASX:IMR): Is it the dark horse in the ASX medtech sector?
Imricor Medical Systems (ASX:IMR) is one of a handful of radiology stocks on the ASX, seeking to emulate the success of Pro Medicus (ASX:PME). There's no shortage of peers including Curvebeam AI (ASX:CVB), Resonance Health (ASX:RHT) and 4D Medical (ASX:4DX). But Imricor just might be the dark horse and we're going to tell you why. What…
September 8, 20250Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here